Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn's Disease: A Propensity Score-Matched Analysis.
Samuel Raimundo FernandesSónia BernardoSofia SaraivaAna Rita GonçalvesPaula Moura SantosAna ValenteLuís Araújo CorreiaHelena Cortez-PintoFernando MagroPublished in: Inflammatory bowel diseases (2023)
Proactive optimization of IFX based on trough levels increases the rates of transmural remission in CD.